Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
India Exempts Rare Disease Drugs, Keytruda From Customs Duty - Is It Enough?
India, China Likely Have Largest Numbers Of Rare Disease Patients
Apr 18 2023
•
By
Vibha Ravi
Tackling Rare Diseases Needs More Policy Measures, Fiscal Incentives • Source: Shutterstock
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from Rare Diseases
More from Pink Sheet